AHPA continues to follow new COVID-19 regulations, guidance and other government actions. The updates below are the latest guidance and other developments since September 6, 2021, to help mitigate the impacts of COVID-19.

HRSA Announces New COVID-19 Relief Funding for Providers and Reporting Grace Period
HRSA announced $25.5 billion in new funding that will be made available to health care providers to reimburse health care related expenses and revenue losses due to COVID-19. HRSA will make $17 billion available through the Provider Relief Fund (PRF) and $8.5 billion available to providers that serve rural patients through American Rescue Plan (ARP) funds. Providers will be able to apply for new funding starting September 29^th.

Biden Administration Announces $3 Billion contribution to Coronavirus Supply Chain
The Biden Administration is committing almost $3 billion to the coronavirus vaccine supply chain as the White House aims to expand U.S. manufacturing of the doses.

HHS Extends PREP Act to Pharmacists Administrating COVID-19 Therapies
HHS amended the Public Readiness and Emergency Preparedness (PREP) Act declaration to provide liability protection to licensed pharmacists, pharmacy technicians, and pharmacy interns to expand the number of providers who can administer COVID-19 therapeutics.